Indonesia Harm Reduction Funding Tracking

Slides:



Advertisements
Similar presentations
TB-HIV POLICY in Indonesia
Advertisements

National Secretariat: Jl. Tebet Timur Dalam XI No. 94, Jakarta, Indonesia Phone: – Fax: –
Project Steering Committee Meeting Colombo, 2012 RAS/H13: Prevention of transmission of HIV among drug users in SAARC countries.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Integrating TB into PWID Services in Indonesia The Works in Progress Dr Siti Nadia, NAP Manager; Dr Dyah Erti Mustikawati, NTP Manager Melbourne AIDS Conference.
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Public-Private Mix (PPM) for TB Control in Global Fund grants Scope and significance SS Lal *, Mukund Uplekar #, Itamar Katz*, Knut Lonnroth #, Ryuichi.
Teresa Guthrie M.PH (Health Economics) HIV modelling for in-country ownership solutions – generation of evidence IAS Conference, Washington DC, July.
 Critical Enablers for HIV, TB & Malaria Responses UNDP & Global Fund informal session 30 th meeting of the Global Fund Board Dr Mandeep Dhaliwal United.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Effective Drugs Policy and Harm Reduction in Tanzania
Successful strategies for supporting regional FLEG declarations Regional Conference on ”Update on the 2005 Saint Petersburg Ministerial Declaration” Tbilisi,
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
AIDS IN ASIA – PRIORITIZING AND SUSTAINING THE RESPONSE IN THE ECONOMIC CRISIS Hanoi September 2009 ADB Consultant Ross McLeod.
1 Current status of harm reduction in Asia International AIDS Conference, Toronto, August 2006 Mr Jimmy Dorabjee Macfarlane Burnet Institute, Melbourne,
© Prof. Rifat Atun. Imperial College London, 2007 The Dublin Declaration Beyond Promises Imperial College London 23 rd November 2007 Professor Rifat Atun.
Country Team Action Plan VIETNAM. Tracks 1 & 2 2 What is the selected best practice? STRENGTHEN LINKING SRH, HIV AND STIS SERVICES IN VIET NAM: SCALING.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan Last updated: December 2014.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan Last updated: January 2016.
Scaling-up harm reduction services towards universal access in Asia Models of good practice ICAAP IX Bali, Indonesia Nai Zindagi, Pakistan.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Law Enforcement agencies and civil society organizations: critical partners in HIV services provision for people who use drugs Zhannat Kosmukhamedova,
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Evidence-based strategic investment to sustain the HIV response Conference on Measuring and Achieving Universal Health Coverage (UHC) with Information.
Aids treatment on the field Experiences from CAMEROON Swiss AIDS platform Aidsfocus Bern, April 2004 Béata UMUBYEYI.
Regulatory System of Research on New Infectious Diseases the Thai Perspective Soraj Hongladarom, Center for Ethics of Science and Technology Chulalongkorn.
Outline Introduction: Harm reduction in Global Fund programs
Key Population Community taking the Lead.
Harm Reduction and CSOs in Transition Period
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Fabienne Hariga Senior Adviser, HIV/AIDS Section
The global state of harm reduction funding
Current harm reduction program at outreach
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Pakistan Last updated: July 2015.
Nebojša Đurasović Vilnius, April 2017.
Key Affected Populations
Adolescents (10-19 yr) Last updated: October 2017.
Edo Agustian Indonesian Drug Users Network
Access Equity in Prisons in Africa A CALL FOR ACTION
Ivan Varentsov Eurasian Harm Reduction Association
Sustainable HIV Financing in Transition (SHIFT)
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
10 by 20 campaign: Strategies for tracking and rebalancing investment in drug law enforcement and harm reduction Emily Rowe, Harm Reduction International.
Jean-Luc SION SANTE C3 Crisis management and preparedness in health
Edward Mbizo Sibanda, (MSc) Right to Care
Adolescents (10-19 yr) Last updated: November 2018.
Global Village Debate This house would ban information dissemination on safe injecting practices, and ban the provision of clean and sterile injecting.
Afghanistan Afghanistan.
China 2010 UNGASS Country Progress Report
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
DECREASES DONOR FUNDING WHAT SHALL BE DONE IF TO FIGHT HIV DRASTICALLY
Strategies for sustainable financing of harm reduction:
Key Affected Populations
Richard Laing WHO/PAU TBS 2013
Campaigning to redirect resources from drug control to harm reduction:
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
HIV Among Gay and Bisexual Men and Other Men Who Have Sex With Men
From "nice-to-have" to "necessary": Increases in domestic financing and the perceived value of key population-led HIV services by the Thai government.
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

Indonesia Harm Reduction Funding Tracking Basic to Sustainability of Harm Reduction Program Ardhany Suryadarma, National Policy Manager Rumah Cemara July, 2018

1. Situation Overview In practice, the government provides support especially in the form of policies that serve as legal and policy guidelines in the program implementation. It is implemented in the community and correctional institutions (prison/ detention centers) setting. Currently there are 3,771 service points for taking HIV tests, 501 clinics that provide ARV services, 187 Puskesmas that provide NSP services throughout Indonesia (MoH, 2016). Every clinic and health-care facility which providing IMS, TB services is also accessible to IDUs in need. Currently there are 92 service point of MMT provided OST through hospitals and community health centers which is held by the government. OST service includes 9 service points in prison / detention center (MoH, 2016) The Harm reduction intervention program has proven by reducing the prevalence of HIV in IDUs from 54% in 2008 to 28% by 2015. However, there are still many challenges to be faced in serving IDUs. www.hri.global

Challenge of the research The working area may change when the funding cycle is completed In the last eight year there was a change of actors which funded and managed the fund on harm reduction program there is no mechanism that makes information about funding programs that can be easily accessed by the public and all harm reduction program which manage the program do not make program and funding reports available to the public. no official report or publication can be used to confirm the answers or information provided no detailed data available on the budget or expenditure of each component of the harm reduction program managed by an institution who implemented HR

Finding Harm Reduction coverage Transparency of spending data Government Investment on Harm Reduction Sustainability of harm reduction program

Advocacy Challenge of the Harm Reduction implementation Local data estimation of PUD and PWID Drug trend change HIV base approach People who use drug facing others problem ( law, social, economic etc. ) National Budget for drug prevention bigger than harm reduction

What must we do? Broader harm reduction perspective Increase the awareness of the society in general to develop collective efforts in pushing the government to invest more on harm reduction Push the government in prioritising public health approach in drug interventions in Indonesia.

Thank you , Hatur Nuhun The Harm Reduction Investment Study is conducted in the frame of the “Harm Reduction Advocacy in Asia (HRAsia)” project (2017-2019). The project is funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria to enable access to HIV and harm reduction services for people who inject drugs in Cambodia, India, Indonesia, Nepal, Philippines, Thailand and Vietnam. The views described herein are the views of Harm Reduction International (HRI), and do not represent the views or opinions of the Global Fund to Fight AIDS, Tuberculosis and Malaria, nor is there any approval or authorization of this material, express or implied, by the Global Fund to Fight AIDS, Tuberculosis and Malaria.